Picture of Vyant Bio logo

VYNT — Vyant Bio News Story

0.000.00%
us flag iconLast trade - 00:00
FinancialsSpeculativeMicro CapNeutral

Brief: Cancer Genetics Filed Prospectus Supplement Related To Offering Of Up To $2.4 Million Of Common Stock

Dec 3 (Reuters) - Cancer Genetics Inc  CGIX.O :
    * CANCER GENETICS FILED PROSPECTUS SUPPLEMENT RELATED TO
OFFERING
OF UP TO $2.4 MILLION OF COMMON STOCK - SEC FILING

Source text for Eikon: [ID:https://bit.ly/3mAqasp]
Further company coverage:  CGIX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Vyant Bio

See all news